Centessa shareholders overwhelmingly approve Eli Lilly acquisition; court hearing set for June 22

Filed June 11, 2026 · Period ending June 12, 2026 · ~1 min read

Key Changes

• high

  Shareholders approved Lilly's acquisition of Centessa with 99.98% voting in favor (126.7M for vs 23K against). All seven shareholders of record voted yes, meeting UK statutory thresholds for the scheme of arrangement.

  Item 5.07: Scheme Meeting Results verify on EDGAR →
• high

  Court hearing to sanction the acquisition scheme scheduled for June 22, 2026 at Royal Courts of Justice in London. This is the final regulatory step before the transaction can close.

  Item 8.01: Court Sanction Hearing verify on EDGAR →
• high

  Shareholders authorized the board to take all necessary actions to implement the Lilly deal, including filing court orders and amending company articles (126.7M votes for).

  Item 5.07: Company GM Resolution verify on EDGAR →